Prevalence of Conjunctivitis and Indentification of Risk Factors With and Without Prophylactic Antibiotic Treatment in Neonates

Centre Hospitalier Universitaire, Amiens881 enrolled

Overview

The French guidelines for the use of Rifamycine eye drops in delivery room to prevent neonatal conjunctivitis have been actualized. Only newborns exposed to risk factors of conjunctivitis should be treated, compared to previous guidelines, treating all newborns. currently, there are no data describing risk factors for neonatal conjunctivitis. This study evaluated the incidence of conjunctivitis with or without Rifamycine eye drops treatment in the delivery room. Then risk factors for neonatal conjunctivitis where analyzed.

Study Type

OBSERVATIONAL

Enrollment

881

Conditions

Ophthalmia Neonatorum

Interventions

Rifamycine treatmentOTHER

Phone prospecting: occurrence of conjunctivitis in newborns treated with rifamycine treatment in delivery room.

Phone prospecting: occurrence of conjunctivitis in newborns did not receive eye drop treatment in delivery room according to new guidelines.

Eligibility

Sex: ALLMin age: 36 WeeksMax age: 36 Weeks

Medical Language ↔ Plain English

Inclusion Criteria: * Newborns at the University Hospital of Amiens\> 36SA, * Admitted in maternity at the exit of nursery Exclusion Criteria: * Newborns at the Amiens University Hospital \<36SA * Eye drops for any medical reason within the first day of life.

Locations (1)

CHU Amiens-Picardie

Amiens, France

Outcomes

Primary Outcomes

Occurrence of conjunctivitis during the first 8 days of life in newborns

Time frame: 8 days

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.